TYK MEDICINES-B(02410): The Hong Kong Stock Exchange has granted approval for the implementation of full circulation of H shares listing.

17:07 12/02/2026

Tongyuan Kang pharmaceuticals -B (02410) announced that the company has applied to the Listing Committee of the Hong Kong Stock Exchange for approval to convert 4.608 million non-listed shares held by one shareholder into 4.608 million H shares for listing and trading after conversion. The Hong Kong Stock Exchange has granted the listing approval on February 11, 2026.

TYK MEDICINES-B(02410) announced that the company has applied to the Listing Committee of the Stock Exchange for approval to convert 4.608 million non-listed shares held by a shareholder of the company into 4.608 million H-shares for listing and trading on the Stock Exchange. The Stock Exchange granted the listing approval on February 11, 2026.

China Galaxy (06881): Qu Yanping was elected as an executive director.

BAIRONG-W (06608) purchased approximately 800,000 shares at a cost of approximately HK$9.01 million on February 12th.

Xiaomi (01810) spent HKD 148 million on February 12 to repurchase 4.05 million shares.

China Galaxy (06881): Qu Yanping was elected as an executive director.

BAIRONG-W (06608) purchased approximately 800,000 shares at a cost of approximately HK$9.01 million on February 12th.

Xiaomi (01810) spent HKD 148 million on February 12 to repurchase 4.05 million shares.